361 related articles for article (PubMed ID: 7561949)
1. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Mantle D; Falkous G; Ishiura S; Perry RH; Perry EK
J Neurol Sci; 1995 Jul; 131(1):65-70. PubMed ID: 7561949
[TBL] [Abstract][Full Text] [Related]
2. Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Mantle D; Falkous G; Ishiura S; Blanchard PJ; Perry EK
Clin Chim Acta; 1996 May; 249(1-2):129-39. PubMed ID: 8737597
[TBL] [Abstract][Full Text] [Related]
3. Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.
Junn E; Ronchetti RD; Quezado MM; Kim SY; Mouradian MM
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2047-52. PubMed ID: 12576551
[TBL] [Abstract][Full Text] [Related]
4. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
Perry EK; Morris CM; Court JA; Cheng A; Fairbairn AF; McKeith IG; Irving D; Brown A; Perry RH
Neuroscience; 1995 Jan; 64(2):385-95. PubMed ID: 7700528
[TBL] [Abstract][Full Text] [Related]
5. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
Duka V; Lee JH; Credle J; Wills J; Oaks A; Smolinsky C; Shah K; Mash DC; Masliah E; Sidhu A
PLoS One; 2013; 8(9):e75025. PubMed ID: 24073234
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
7. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain.
Cataldo AM; Nixon RA
Proc Natl Acad Sci U S A; 1990 May; 87(10):3861-5. PubMed ID: 1692625
[TBL] [Abstract][Full Text] [Related]
8. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.
Davis MY; Keene CD; Jayadev S; Bird T
J Huntingtons Dis; 2014; 3(2):209-17. PubMed ID: 25062863
[TBL] [Abstract][Full Text] [Related]
9. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
[TBL] [Abstract][Full Text] [Related]
11. A pathological study of the association between Lewy body disease and Alzheimer's disease.
Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
[TBL] [Abstract][Full Text] [Related]
12. AMPK in Neurodegenerative Diseases.
Domise M; Vingtdeux V
Exp Suppl; 2016; 107():153-177. PubMed ID: 27812980
[TBL] [Abstract][Full Text] [Related]
13. Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.
Hansen LA; Daniel SE; Wilcock GK; Love S
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):653-6. PubMed ID: 9598683
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.
Atkinson A; Singleton AB; Steward A; Ince PG; Perry RH; McKeith IG; Fairbairn AF; Edwardson JA; Daly AK; Morris CM
Pharmacogenetics; 1999 Feb; 9(1):31-5. PubMed ID: 10208640
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
Kawamoto Y; Ito H; Ihara M; Takahashi R
Neuroreport; 2012 Feb; 23(3):162-7. PubMed ID: 22273571
[TBL] [Abstract][Full Text] [Related]
16. Simplified neuropathological diagnosis of dementia with Lewy bodies.
Harding AJ; Halliday GM
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):195-201. PubMed ID: 9717184
[TBL] [Abstract][Full Text] [Related]
17. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.
Gnanalingham KK; Byrne EJ; Thornton A; Sambrook MA; Bannister P
J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):243-52. PubMed ID: 9069479
[TBL] [Abstract][Full Text] [Related]
18. [Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)].
Schneider G; Oepen H; von Wedel HR
Arch Psychiatr Nervenkr (1970); 1981; 230(1):5-15. PubMed ID: 6455104
[TBL] [Abstract][Full Text] [Related]
19. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients.
Ince P; Irving D; MacArthur F; Perry RH
J Neurol Sci; 1991 Dec; 106(2):142-52. PubMed ID: 1802962
[TBL] [Abstract][Full Text] [Related]
20. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
